Results 161 to 170 of about 2,521,110 (208)

Comparative oral monotherapy of psilocybin, lysergic acid diethylamide, 3,4-methylenedioxymethamphetamine, ayahuasca, and escitalopram for depressive symptoms: systematic review and Bayesian network meta-analysis.

BMJ
Hsu TW, Tsai CK, Kao YC, Thompson T, Carvalho AF, Yang FC, Tseng PT, Hsu CW, Yu CL, Tu YK, Liang CS.   +10 more
europepmc   +1 more source

Some of the next articles are maybe not open access.

Related searches:

Mass Spectrometry of Lysergic Acid Diethylamide

Journal of Pharmaceutical Sciences, 1969
I C, Nigam, J, Holmes
exaly   +3 more sources

Metabolism of Lysergic Acid Diethylamide

Nature, 1956
IN a communication on lysergic acid diethylamide, Axelrod, Brady, Witkop and Evarts1 state: “Although the hallucinogenic agent, lysergic acid diethylamide, has been the subject of numerous investigations, little is known about its biological fate”. However, a number of facts, not mentioned in this communication, about the destruction, distribution and ...
J, AXELROD, R O, BRADY, B, WITKOP, E V, EVARTS   +3 more
openaire   +4 more sources

Electrochemistry and analytical determination of lysergic acid diethylamide (LSD) via adsorptive stripping voltammetry

Talanta, 2014
Lysergic acid diethylamide (LSD) is hardly detectable and quantifiable in biological samples because of its low active dose. Although several analytical tests are available, routine analysis of this drug is rarely performed.
Stefano Protti, Daniele Merli
exaly   +2 more sources

Acute Effects of Lysergic Acid Diethylamide on Circulating Steroid Levels in Healthy Subjects [PDF]

Journal of Neuroendocrinology, 2016
Lysergic acid diethylamide (LSD) is a serotonin 5-hydroxytryptamine-2A (5-HT2A ) receptor agonist that is used recreationally worldwide. Interest in LSD research in humans waned after the 1970s, although the use of LSD in psychiatric research and ...
Patrick C Dolder, Yasmin Schmid, Katharina M Rentsch   +2 more
exaly   +3 more sources